BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program

  August 5, 2025

   · 

  8 min read
• Press Releases

  Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results

  August 5, 2025

   · 

  15 min read
• Press Releases

  Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes

  August 5, 2025

   · 

  5 min read
• Press Releases

  Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production

  August 5, 2025

   · 

  3 min read
• Press Releases

  Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

  August 5, 2025

   · 

  4 min read
• Press Releases

  Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

  August 5, 2025

   · 

  5 min read
• Press Releases

  Capsa Healthcare Acquires BlueBin to Advance Intelligent Clinical Supply Management

  August 5, 2025

   · 

  2 min read
• Press Releases

  AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval

  August 5, 2025

   · 

  3 min read
• Press Releases

  Advarra Appoints Brian Hart as Chief Technology Officer

  August 5, 2025

   · 

  2 min read
• Press Releases

  Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial

  August 5, 2025

   · 

  4 min read